[ad_1]
Switzerland eagerly awaits the third crown vaccine. But the British manufacturer’s vaccine is likely only given to people under 65.
Older people in particular need the syringe, but the efficacy of the AstraZeneca vaccine is unclear to them.
Photo: Adrian Dennis (AFP)
The AstraZeneca vaccine should receive the green light from Swissmedic in early February. However, it is already likely not approved for people 65 and older. The German Vaccination Commission also recommends that the vaccine only be used in people up to 64 years of age. In the EU, the serum will most likely be approved after this Friday.
“As with any drug approval, restrictions may initially be imposed for certain ages and risk groups if they were not sufficiently represented in clinical studies,” Swissmedic spokesman Lukas Jaggi says upon request. It is quite possible that admission to Switzerland is only for young people. In Great Britain, the AstraZeneca vaccine is approved for the elderly. But: “Data on efficacy and safety are currently limited to people aged 65 and over,” says Brit Product information about the vaccine.
